Safety comparison of omalizumab and glucocorticoid in rush allergen immunotherapy

To observe the safety of omalizumab and glucocorticoid in the dose-increasing phase of rush allergen immunotherapy（RIT）. The clinical data of 88 patients with allergic rhinitis treated with RIT were retrospectively studied, including gender, age, pre-treatment total VAS score, blood EOS%, serum tota...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery head, and neck surgery, 2020-07, Vol.34 (7), p.610-614
Hauptverfasser:	Gao, Pei, Yu, Wenting, Zhou, Yue, Zhu, Wanting, Zhu, Zhenchao, Jiang, Yinli, Cheng, Qing, Wang, Yanjun, Kong, Weijia, Zhu, Xinhua, Qiu, Qianhui, Chen, Jianjun
Format:	Artikel
Sprache:	chi
Schlagworte:	Allergens Desensitization, Immunologic Glucocorticoids Humans Immunotherapy Omalizumab Retrospective Studies Rhinitis, Allergic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!